BYETTA bør ikke bruges til patienter med terminal nyresygdom eller svært nedsat nyrefunktion (kreatinin- clearance < 30 ml/ min).
BYETTA is not recommended for use in patients with end-stage renal disease or severe renal impairment (creatinine clearance < 30 ml/ min).